Suppr超能文献

合并症对慢性乙型肝炎发病时严重程度的影响。

Impact of comorbidities on the severity of chronic hepatitis B at presentation.

机构信息

Department of Public Medicine, Section of Infectious Diseases, Second University of Naples, 80132 Naples, Italy.

出版信息

World J Gastroenterol. 2012 Apr 14;18(14):1616-21. doi: 10.3748/wjg.v18.i14.1616.

Abstract

AIM

To evaluate the clinical relevance of each cofactor on clinical presentation of chronic hepatitis B.

METHODS

Out of 1366 hepatitis B surface antigen (HBsAg) positive subjects consecutively observed in 79 Italian hospitals, 53 (4.3%) showed as the only cofactor hepatitis D virus (HDV) infection [hepatitis B virus (HBV)/HDV group], 130 (9.5%) hepatitis C virus (HCV) (group HBV/HCV), 6 (0.4%) human immunodeficiency virus (HIV) (group HBV/HIV), 138 (10.2%) alcohol abuse (group HBV/alcohol); 109 (8.0%) subjects had at least two cofactors and 924 were in the cofactor-free (CF) group.

RESULTS

Compared with patients in group CF those in group HBV/alcohol were older and more frequently had cirrhosis (P < 0.001), those in group HBV/HDV were younger (P < 0.001), more frequently resided in the south of the country and had cirrhosis (P <0.001), those in group HBV/HCV were older (P < 0.001) and more frequently had cirrhosis (P < 0.001). These cofactors were all independent predictors of liver cirrhosis in HBsAg positive patients. Multivariate analysis showed that an older age [odds ratio (OR) 1.06, 95% CI: 1.05-1.08], alcohol abuse with more than 8 drinks daily (OR 2.89, 95% CI: 1.81-4.62) and anti-HDV positivity (OR 3.48, 95% CI: 2.16-5.58) are all independently associated with liver cirrhosis. This association was found also for anti-HCV positivity in univariate analysis, but it was no longer associated (OR 1.23, 95% CI: 0.84-1.80) at multivariate analysis.

CONCLUSION

Older age, HDV infection and alcohol abuse are the major determinants of severe liver disease in chronic HBV infection, while HCV replication plays a lesser role in the severity of hepatic damage.

摘要

目的

评估每个伴随因子在慢性乙型肝炎临床表型中的临床相关性。

方法

在意大利 79 家医院连续观察的 1366 例乙型肝炎表面抗原(HBsAg)阳性患者中,53 例(4.3%)仅有乙型肝炎丁型病毒(HDV)感染作为伴随因子[乙型肝炎病毒(HBV)/HDV 组],130 例(9.5%)为丙型肝炎病毒(HCV)(HBV/HCV 组),6 例(0.4%)为人类免疫缺陷病毒(HIV)(HBV/HIV 组),138 例(10.2%)为酒精滥用(HBV/酒精组);109 例(8.0%)患者有至少两种伴随因子,924 例为无伴随因子(CF)组。

结果

与 CF 组患者相比,HBV/酒精组患者年龄较大,更常发生肝硬化(P < 0.001);HBV/HDV 组患者年龄较小(P < 0.001),更常居住在该国南部,且更常发生肝硬化(P < 0.001);HBV/HCV 组患者年龄较大(P < 0.001),更常发生肝硬化(P < 0.001)。这些伴随因子都是 HBsAg 阳性患者发生肝硬化的独立预测因子。多变量分析显示,年龄较大(比值比[OR]1.06,95%置信区间[CI]:1.05-1.08)、每日饮酒超过 8 杯(OR 2.89,95%CI:1.81-4.62)和抗-HDV 阳性(OR 3.48,95%CI:2.16-5.58)均与肝硬化独立相关。在单变量分析中也发现抗-HCV 阳性与肝硬化相关,但在多变量分析中不再相关(OR 1.23,95%CI:0.84-1.80)。

结论

年龄较大、HDV 感染和酒精滥用是慢性 HBV 感染严重肝脏疾病的主要决定因素,而 HCV 复制在肝损伤严重程度中的作用较小。

相似文献

1
Impact of comorbidities on the severity of chronic hepatitis B at presentation.
World J Gastroenterol. 2012 Apr 14;18(14):1616-21. doi: 10.3748/wjg.v18.i14.1616.
2
The medical impact of hepatitis D virus infection in Uzbekistan.
Liver Int. 2019 Nov;39(11):2077-2081. doi: 10.1111/liv.14243. Epub 2019 Sep 20.
3
Multiple hepatitis virus infections in chronic HBsAg carriers in Naples.
Arch Virol. 1997;142(3):445-51. doi: 10.1007/s007050050090.
8
Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
J Viral Hepat. 2010 Jan;17(1):65-76. doi: 10.1111/j.1365-2893.2009.01153.x. Epub 2009 Aug 4.

引用本文的文献

1
Metabolic disorders and hepatitis: Insights from a Mendelian randomization study.
World J Gastrointest Surg. 2024 Jun 27;16(6):1775-1790. doi: 10.4240/wjgs.v16.i6.1775.
2
The exposome and liver disease - how environmental factors affect liver health.
J Hepatol. 2023 Aug;79(2):492-505. doi: 10.1016/j.jhep.2023.02.034. Epub 2023 Mar 6.
5
Hepatitis D virus infection in a large cohort of immigrants in southern Italy: a multicenter, prospective study.
Infection. 2022 Dec;50(6):1565-1572. doi: 10.1007/s15010-022-01938-0. Epub 2022 Oct 12.
6
Epidemiological and clinical aspects of hepatitis B virus infection in Italy over the last 50 years.
World J Gastroenterol. 2022 Jul 14;28(26):3081-3091. doi: 10.3748/wjg.v28.i26.3081.
7
HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers.
Biomedicines. 2022 Mar 25;10(4):768. doi: 10.3390/biomedicines10040768.
8
Viral hepatitis update: Progress and perspectives.
World J Gastroenterol. 2021 Jul 14;27(26):4018-4044. doi: 10.3748/wjg.v27.i26.4018.
9
COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States.
EClinicalMedicine. 2021 Jan;31:100688. doi: 10.1016/j.eclinm.2020.100688. Epub 2020 Dec 22.

本文引用的文献

1
Hepatitis delta virus.
Lancet. 2011 Jul 2;378(9785):73-85. doi: 10.1016/S0140-6736(10)61931-9. Epub 2011 Apr 20.
2
HDV: thirty years later.
Dig Liver Dis. 2011 Jan;43 Suppl 1:S15-8. doi: 10.1016/S1590-8658(10)60687-1.
3
Outcome of chronic delta hepatitis in Italy: a long-term cohort study.
J Hepatol. 2010 Nov;53(5):834-40. doi: 10.1016/j.jhep.2010.06.008. Epub 2010 Jul 29.
7
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 2007 Jun;132(7):2557-76. doi: 10.1053/j.gastro.2007.04.061.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验